A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases

Data availability

The crystal structure of the FXR–linafexor complex bound to the second LXXLL peptide motif from SRC2 has been deposited in the PDB under PDB ID 9LQ3 . Superposition of the linafexor-bound FXR complex with the tropifexor-bound structure can be found under PDB ID 7D42 . The transcriptomics data were uploaded to the National Genomics Data Center ( https://ngdc.cncb.ac.cn/gsa/ ; reference ID CRA038114 ). Source data are provided with this paper.

References

Evans, R. M. & Mangelsdorf, D. J. Nuclear receptors, RXR, and the Big Bang. Cell 157 , 255–266 (2014).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Parks, D. J. et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 284 , 1365–1368 (1999).

Article

ADS

CAS

PubMed

Google Scholar

Schalm, S. W. et al. Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid. Gut 19 , 1006–1014 (1978).

Article

CAS

PubMed

PubMed Central

Google Scholar

Hofmann, A. F. & Hagey, L. R. Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades. J. Lipid Res. 55 , 1553–1595 (2014).

Article

CAS

PubMed

PubMed Central

Google Scholar

Cowen, A. E., Korman, M. G., Hofmann, A. F. & Thomas, P. J. Plasma disappearance of radioactivity after intravenous injection of labeled bile acids in man. Gastroenterology 68 , 1567–1573 (1975).

Article

CAS

PubMed

Google Scholar

Hansen, H. H. et al. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. BMC Gastroenterol. 20 , 210 (2020).

Article

CAS

PubMed

PubMed Central

Google Scholar

Matsumoto, M. et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int. J. Exp. Pathol. 94 , 93–103 (2013).

Article

CAS

PubMed

PubMed Central

Google Scholar

Fukumoto, Y. et al. Studies of alpha-napthylisothiocyanate-induced hepatic disturbance. Hepatogastroenterology   27 , 457–464 (1980).

CAS

PubMed

Google Scholar

Fickert, P. et al. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am. J. Pathol. 171 , 525–536 (2007).

Article

CAS

PubMed

PubMed Central

Google Scholar

Sanyal, A. J. et al. Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nat. Med. 29 , 392–400 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Neuschwander-Tetri, B. A. et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385 , 956–965 (2015).

Article

CAS

PubMed

Google Scholar

Holt, J. A. et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17 , 1581–1591 (2003).

Article

CAS

PubMed

PubMed Central

Google Scholar

Han, S. et al. Circadian control of bile acid synthesis by a KLF15-Fgf15 axis. Nat. Commun. 6 , 7231 (2015).

Article

ADS

CAS

PubMed

Google Scholar

Inagaki, T. et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2 , 217–225 (2005).

Article

CAS

PubMed

Google Scholar

Sherman, C. A. & Hanson, R. F. Bile acid biosynthesis: the metabolism of 7 alpha-hydroxy-4-cholesten-3-one in the bile fistula rat. Steroids 27 , 145–153 (1976).

Article

CAS

PubMed

Google Scholar

Wouters, O. J., McKee, M. & Luyten, J. Estimated research and development investment needed to bring a new medicine to market, 2009–2018. J. Am. Med. Assoc. 323 , 844–853 (2020).

Article

Google Scholar

Thomas, D. W. et al. Clinical Development Success Rates 2006-2015 (Biotechnology Innovation Organization, Biomedtracker, Amplion, 2016).

Arrowsmith, J. & Miller, P. Trial watch: phase II and phase III attrition rates 2011–2012. Nat. Rev. Drug Discov. 12 , 569 (2013).

Article

CAS

PubMed

Google Scholar

Scannell, J. W., Blanckley, A., Boldon, H. & Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11 , 191–200 (2012).

Article

CAS

PubMed

Google Scholar

Derendorf, H. & Meibohm, B. Modeling of Pharmacokinetic/pharmacodynamic (pk/pd) relationships: concepts and perspectives. Pharm. Res. 16 , 176–185 (1999).

Article

CAS

PubMed

Google Scholar

Kuipers, F., Bloks, V. W. & Groen, A. K. Beyond intestinal soap–bile acids in metabolic control. Nat. Rev. Endocrinol. 10 , 488–498 (2014).

Article

CAS

PubMed

Google Scholar

Li, T. & Chiang, J. Y. L. Bile acids as metabolic regulators: an update. Curr. Opin. Gastroenterol. 39 , 249–255 (2023).

Article

PubMed

Google Scholar

de Aguiar Vallim, T. Q., Tarling, E. J. & Edwards, P. A. Pleiotropic roles of bile acids in metabolism. Cell M…